{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:39:45Z","timestamp":1779896385972,"version":"3.53.1"},"reference-count":42,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,7,23]],"date-time":"2013-07-23T00:00:00Z","timestamp":1374537600000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Novel psychoactive substances (NPS; a.k.a. \u2018legal highs\u2019 or \u2018smart drugs\u2019) are advertised online as \u2018safe\u2019 and \u2018legal\u2019 natural\/synthetic analogues of controlled illicit drugs. However, only little research has been carried out in identifying the health professionals' knowledge and expertise relating to the intake of these compounds.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data presented here refer to the Italian component of the European Union\u2010wide, European Commission\u2010funded, ReDNet project survey. An ad\u2010hoc questionnaire was administered to professionals from the departments of Addiction, Psychiatry, Paediatrics and Emergency Room Services in Italy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The interviewees' sample included 243 professionals, mostly from the departments of Addiction (35%) and Psychiatry (28.4%). Overall, interviewees self\u2010reported a poor technical knowledge relating to NPS; some 27% of respondents confirmed of not being aware if their patients presented with a previous history of NPS misuse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Novel psychoactive substances prevalence of misuse was not considered to be an unusual phenomenon in Italy, and most health professionals appeared to have concerns relating to associated medical and psychopathological risks, especially in terms of aggression\/psychomotor agitation. Overall, most respondents reported the need to have better access to NPS\u2010related reliable sources of information. Copyright \u00a9 2013 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hup.2300","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T17:20:13Z","timestamp":1374686413000},"page":"324-331","source":"Crossref","is-referenced-by-count":56,"title":["Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey"],"prefix":"10.1002","volume":"28","author":[{"given":"Pierluigi","family":"Simonato","sequence":"first","affiliation":[{"name":"School of Life and Medical Sciences University of Hertfordshire  Hatfield UK"},{"name":"Psychiatric Clinic, Department of Neurosciences University Hospital of Padova  Padova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Corazza","sequence":"additional","affiliation":[{"name":"School of Life and Medical Sciences University of Hertfordshire  Hatfield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Santonastaso","sequence":"additional","affiliation":[{"name":"Psychiatric Clinic, Department of Neurosciences University Hospital of Padova  Padova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Corkery","sequence":"additional","affiliation":[{"name":"School of Life and Medical Sciences University of Hertfordshire  Hatfield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Deluca","sequence":"additional","affiliation":[{"name":"Addictions Department, Institute of Psychiatry King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Davey","sequence":"additional","affiliation":[{"name":"Addictions Department, Institute of Psychiatry King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Blaszko","sequence":"additional","affiliation":[{"name":"Addictions Department, Institute of Psychiatry King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Schifano","sequence":"additional","affiliation":[{"name":"School of Life and Medical Sciences University of Hertfordshire  Hatfield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,23]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"ACMD.2011.Consideration of the Novel Psychoactive Substances (\u2018Legal Highs\u2019) Advisory Council on the Misuse of Drugs London."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.11.270"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","unstructured":"BajajN MullenD WylieS.2010.Dependence and psychosis with 4\u2010methylmethcathinone (mephedrone) use.BMJ Case Reports 2010.","DOI":"10.1136\/bcr.02.2010.2780"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-9877(03)00307-4"},{"key":"e_1_2_8_6_1","unstructured":"Bowden\u2010JonesO.2012.One year results from a UK specialist club drug clinic. Who presented and what are they using. Presentation atThe First International Conference on Novel Psychoactive Substances(NPS) \u2010 \u201cThe Ever\u2010Changing World of Psychoactive Drugs\u201d12\u201313 March Budapest."},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/14659890903060167"},{"key":"e_1_2_8_8_1","first-page":"43","article-title":"Le nuove potenzialit\u00e0 della prevenzione digitale in materia di nuove droghe: il ruolo del Recreational Drugs European Network","volume":"2","author":"Corazza O","year":"2010","journal-title":"Dipendenze Patologiche \/ Addictive Behaviors"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/157488411796151129"},{"issue":"1","key":"e_1_2_8_10_1","first-page":"25","article-title":"Novel drugs, novel solutions: exploring the potentials of web\u2010assistance and multimedia approaches for the prevention of drug abuse","volume":"1","author":"Corazza O","year":"2011","journal-title":"Italian Journal on Addiction"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1242"},{"key":"e_1_2_8_12_1","unstructured":"CorazzaO DemetrovicsZ van denBrinkW SchifanoF.2012bAug 7.Reasons for avoiding the term \u201clegal highs\u201d for \u201cnovel psychoactive drugs\u201d in drug prevention and scientific debates. International Journal of Drug Policy. [Epub ahead of print]"},{"key":"e_1_2_8_13_1","first-page":"355","article-title":"Mephedrone\u2010related fatalities in the United Kingdom: contextual, clinical and practical issues","author":"Corkery J","year":"2012","journal-title":"Pharmacology"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/09638237.2012.682265"},{"key":"e_1_2_8_15_1","unstructured":"DelucaP DaveyZ CorazzaO et al.2012Jul 27.Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Progress in Neuropsychopharmacology and Biological Psychiatry. [Epub ahead of print]"},{"key":"e_1_2_8_16_1","unstructured":"EMCDDA.2011a.EMCDDA report 2011: the state of the drugs problem in Europe Annual Report from EMCDDA Lisbon 2011."},{"key":"e_1_2_8_17_1","unstructured":"EMCDDA.2011b.First international multidisciplinary forum on new drugs. 11\u201312 May 2011 Lisbon."},{"key":"e_1_2_8_18_1","unstructured":"EMCDDA.2011c.Online sales of New Psychoactive Substances\/\u2018Legal Highs\u2019: summary of results from the 2011 multilingual snapshots.EMCDDAReport Lisbon November 2011"},{"key":"e_1_2_8_19_1","unstructured":"EMCDDA.2012.New drugs detected in the EU at the rate of around one per week say agencies. Available from:http:\/\/www.emcdda.europa.eu\/news\/2012\/2(accessed 21 August 2012)"},{"key":"e_1_2_8_20_1","unstructured":"EMCDDA\u2010Europol.2010.Annual Report on the implementation of Council Decision 2005\/387\/JHA Lisbon."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2006.02.008"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-006-0039-6"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826080903443628"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.10.018"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2010.12.014"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/anatox\/35.3.188"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.09.008"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm054"},{"issue":"10","key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1176\/ps.2006.57.10.1468","article-title":"Diagnosing psychotic disorders in the emergency department in the context of substance use","volume":"57","author":"Schanzer B","year":"2006","journal-title":"Psychiatr Serv"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1089\/109493103322278790"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.528"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105056660"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106060147"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181612cdc"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-2070-x"},{"key":"e_1_2_8_36_1","unstructured":"SedefovR GallegosA.2011.Risks assessments. Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances EMCDDA.EMCDDA Report Lisbon May 2011."},{"issue":"1","key":"e_1_2_8_37_1","first-page":"43","article-title":"Rapporto sulla Prima Conferenza Internazionale sulle Nuove Sostanze Psicoattive (NPS). \u201cThe Ever\u2010Changing World of Psychoactive Drugs\u201d, Budapest, 12\u201313 March 2012","volume":"2","author":"Simonato P","year":"2012","journal-title":"Italian Journal on Addiction"},{"key":"e_1_2_8_38_1","unstructured":"UNODC.2011.Global Smart Update 2011 United Nations Office on Drugs and Crime. Vol.6 October 2011."},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2011.566501"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03130.x"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1199-9"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.3109\/14659891.2012.661025"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-010-0018-5"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2300","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.2300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T04:52:51Z","timestamp":1697518371000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.2300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1002\/hup.2300"],"URL":"https:\/\/doi.org\/10.1002\/hup.2300","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}